CLINICAL AND HEALTH OUTCOMES ASSOCIATED WITH TREATMENT SEQUENCES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
Marla C. Dubinsky 1
Simone Rivolo 2
Manasi Suryavanshi 3
Apoorva Ambavane 3
Neeharika Agnihotri 3
Conrado Franco-Villalobos 3
Mark T. Osterman 3
Komal Gupte-Singh 3
1 Icahn School of Medicine at Mount Sinai, New York City, United States
2 Evidera, Inc., London, United Kingdom
3 Bristol Myers Squibb, Princeton, United States
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]